[HTML][HTML] Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities
B Bournet, C Buscail, F Muscari, P Cordelier… - European journal of …, 2016 - Elsevier
Mutation of the KRAS oncogene in pancreatic cancer is responsible for permanent activation
of the P21 RAS protein and the cascade of signalling pathways. Consequently, multiple …
of the P21 RAS protein and the cascade of signalling pathways. Consequently, multiple …
[HTML][HTML] Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management
N Gupta, R Yelamanchi - World journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer is one of the dreaded malignancies for both the patient and the clinician.
The five-year survival rate of pancreatic adenocarcinoma (PDA) is as low as 2% despite …
The five-year survival rate of pancreatic adenocarcinoma (PDA) is as low as 2% despite …
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
Y Nakano, S Tanno, K Koizumi, T Nishikawa… - British journal of …, 2007 - nature.com
To identify predictive molecular markers for gemcitabine resistance, we investigated
changes in the expression of four genes associated with gemcitabine transport and …
changes in the expression of four genes associated with gemcitabine transport and …
Inflammation and cancer: role of nuclear factor‐kappaB activation
S Maeda, M Omata - Cancer science, 2008 - Wiley Online Library
It has been thought that there is a strong relationship between inflammation and
carcinogenesis so that the development of cancer occurs with chronic inflammation in many …
carcinogenesis so that the development of cancer occurs with chronic inflammation in many …
Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients
M Tada, T Kawabe, M Arizumi, O Togawa… - Clinical …, 2006 - Elsevier
Background & Aims: K-ras mutation is frequently detected in pancreatic juice of patients with
pancreatic small cystic lesions, as well as those with pancreatic cancer. Those cystic lesions …
pancreatic small cystic lesions, as well as those with pancreatic cancer. Those cystic lesions …
Role of endoscopic ultrasound‐guided fine needle aspiration (EUS‐FNA) for diagnosis of solid pancreatic masses
S Yoshinaga, H Suzuki, I Oda, Y Saito - Digestive Endoscopy, 2011 - Wiley Online Library
Since it was developed in 1992, endoscopic ultrasound‐guided fine needle aspiration (EUS‐
FNA) has been widely used and has been adapted for gastrointestinal and …
FNA) has been widely used and has been adapted for gastrointestinal and …
EUS-guided FNA
RA Erickson - Gastrointestinal endoscopy, 2004 - giejournal.org
VOLUME 60, NO. 2, 2004 GASTROINTESTINAL ENDOSCOPY 267 cytologic brushing is as
high as 11% for the biliary tree and 21% for pancreatic strictures. 11, 12, 30 This morbidity …
high as 11% for the biliary tree and 21% for pancreatic strictures. 11, 12, 30 This morbidity …
The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of …
Background Differential diagnosis of pancreatic solid masses with EUS-guided FNA (EUS-
FNA) is still challenging in about 15% of cases. Mutation of the K-ras gene is present in over …
FNA) is still challenging in about 15% of cases. Mutation of the K-ras gene is present in over …
Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction
Y Nakai, H Isayama, Y Komatsu, T Tsujino… - Gastrointestinal …, 2005 - Elsevier
BACKGROUND: The aim of this study was to evaluate the efficacy and the safety of the
covered Wallstent, a commercially available silicone-covered, self-expandable metallic stent …
covered Wallstent, a commercially available silicone-covered, self-expandable metallic stent …
Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA
K Takahashi, K Yamao, K Okubo, A Sawaki… - Gastrointestinal …, 2005 - Elsevier
BACKGROUND: Despite advances in diagnostic imaging techniques, the differentiation
between pancreatic cancer and focal pancreatitis remains difficult. This study evaluated the …
between pancreatic cancer and focal pancreatitis remains difficult. This study evaluated the …